Insights

CND Life Sciences Launches Patient Matters Video Series to Highlight the Importance of the Syn-One Test™ in Diagnosing Neurological Disorders

By January 29, 2021 No Comments

CND Life Sciences Launches Patient Matters Video Series to Highlight the Importance of the Syn-One Test™ in Diagnosing Neurological Disorders

A core value of CND Life Sciences is putting patients first. We understand that there’s a patient behind every Syn-One Test™ we perform. That’s why we’re launching the Patient Matters video series—hosted by former CNN anchor Daryn Kagan—to bring those patients’ stories to the forefront and demonstrate the importance of the Syn-One Test in helping clinicians make an objective and accurate diagnosis. 

It’s not uncommon for patients with Parkinson’s disease, dementia with Lewy bodies, and other synucleinopathies to suffer for years with unexplained symptoms before getting a correct diagnosis. That’s why we spent 10 years developing the Syn-One Test to help clinicians diagnose neurodegenerative disorders with increased clarity and confidence as early in the disease process as possible. 

We’re launching our video series with a story about a patient struggling with symptoms but not finding answers, even after an extensive battery of tests and trying several medications. Then his doctor used the Syn-One Test, and the results helped the pieces fall into place.  

“I look back at all those other tests and I think ‘Why did I undergo all of those? Why didn’t I start with just this?’” 

Watch the full story here.